Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Operating Leases (2020 - 2025)

IceCure Medical (ICCM) has disclosed Operating Leases for 5 consecutive years, with $459000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Operating Leases fell 23.37% to $459000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $459000.0, a 23.37% decrease, with the full-year FY2024 number at $459000.0, down 23.37% from a year prior.
  • Operating Leases was $459000.0 for Q4 2024 at IceCure Medical, down from $599000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $685000.0 in Q4 2021 to a low of $118000.0 in Q4 2020.
  • A 5-year average of $458200.0 and a median of $459000.0 in 2024 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: soared 480.51% in 2021, then tumbled 37.23% in 2022.
  • IceCure Medical's Operating Leases stood at $118000.0 in 2020, then skyrocketed by 480.51% to $685000.0 in 2021, then crashed by 37.23% to $430000.0 in 2022, then surged by 39.3% to $599000.0 in 2023, then fell by 23.37% to $459000.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Operating Leases are $459000.0 (Q4 2024), $599000.0 (Q4 2023), and $430000.0 (Q4 2022).